Systematic Coronary Risk Evaluation 2 (SCORE2)
ورودیهای بالینی بیمار
حداقل ۴۰ — حداکثر ۶۹ • واحد: years
حداقل ۸۰ — حداکثر ۲۵۰ • واحد: mmHg
حداقل ۲ — حداکثر ۱۲ • واحد: mmol/L
حداقل ۰.۵ — حداکثر ۳.۵ • واحد: mmol/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low to Moderate Risk (<50 years)0–2.5
- High Risk (<50 years) / Low to Moderate Risk (50-69 years)2.5–5
- High Risk (<50 years) / High Risk (50-69 years)5–7.5
- Very High Risk (<50 years) / High Risk (50-69 years)7.5–10
The Systematic Coronary Risk Evaluation 2 (SCORE2) calculator is designed for bedside predicting 10-year risk of cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) in patients aged 40-69 without prior cardiovascular disease or diabetes in clinical practice. The resulting score directly guides clinician decision-making.
Clinical Guidelines & Evidence
Predicts 10-year risk of cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) in patients aged 40-69 without prior cardiovascular disease or diabetes.
Clinical Indication
The Systematic Coronary Risk Evaluation 2 (SCORE2) is indicated for bedside clinical practice to support Predicts 10-year risk of cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) in patients aged 40-69 without prior cardiovascular disease or diabetes.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
10-year risk = 1 - S0(10)^exp(x), where x = Σ[β × transformed_variables]. Variables are transformed: cage=(age-60)/5, csbp=(SBP-120)/20, ctot=(total_chol-6)/1, chdl=(HDL-1.3)/0.5. Coefficients vary by sex and risk region.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| sex | string | Yes | Biological sex |
| age | integer | Yes | Age in years(years) |
| smoking | string | Yes | Current smoking status |
| systolic_bp | integer | Yes | Systolic blood pressure(mmHg) |
| total_cholesterol | float | Yes | Total cholesterol(mmol/L) |
| hdl_cholesterol | float | Yes | HDL cholesterol(mmol/L) |
| risk_region | string | Yes | Cardiovascular risk region based on country |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2.5 | Low to Moderate Risk (<50 years) | <2.5% 10-year risk |
| 2.5–5 | High Risk (<50 years) / Low to Moderate Risk (50-69 years) | 2.5-5% 10-year risk |
| 5–7.5 | High Risk (<50 years) / High Risk (50-69 years) | 5-7.5% 10-year risk |
| 7.5–10 | Very High Risk (<50 years) / High Risk (50-69 years) | 7.5-10% 10-year risk |
| 10–100 | Very High Risk | ≥10% 10-year risk |
Evidence-Based References (EBM)
- Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.DOI: 10.1093/eurheartj/ehab484
- SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021 Jul 1;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309.DOI: 10.1093/eurheartj/ehab309
- Hageman S, Pennells L, Ojeda F, Kaptoge S, Kuulasmaa K, de Vries T, et al. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021 Jul 1;42(25):2439-2454.